Literature DB >> 23598956

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Wouter Hoefsloot1, Jakko van Ingen, Claire Andrejak, Kristian Angeby, Rosine Bauriaud, Pascale Bemer, Natalie Beylis, Martin J Boeree, Juana Cacho, Violet Chihota, Erica Chimara, Gavin Churchyard, Raquel Cias, Rosa Daza, Charles L Daley, P N Richard Dekhuijzen, Diego Domingo, Francis Drobniewski, Jaime Esteban, Maryse Fauville-Dufaux, Dorte Bek Folkvardsen, Noel Gibbons, Enrique Gómez-Mampaso, Rosa Gonzalez, Harald Hoffmann, Po-Ren Hsueh, Alexander Indra, Tomasz Jagielski, Frances Jamieson, Mateja Jankovic, Eefje Jong, Joseph Keane, Wo-Jung Koh, Berit Lange, Sylvia Leao, Rita Macedo, Turid Mannsåker, Theodore K Marras, Jeannette Maugein, Heather J Milburn, Tamas Mlinkó, Nora Morcillo, Kozo Morimoto, Dimitrios Papaventsis, Elia Palenque, Mar Paez-Peña, Claudio Piersimoni, Monika Polanová, Nalin Rastogi, Elvira Richter, Maria Jesus Ruiz-Serrano, Anabela Silva, M Pedro da Silva, Hulya Simsek, Dick van Soolingen, Nora Szabó, Rachel Thomson, Teresa Tórtola Fernandez, Enrico Tortoli, Sarah E Totten, Greg Tyrrell, Tuula Vasankari, Miguel Villar, Renata Walkiewicz, Kevin L Winthrop, Dirk Wagner.   

Abstract

A significant knowledge gap exists concerning the geographical distribution of nontuberculous mycobacteria (NTM) isolation worldwide. To provide a snapshot of NTM species distribution, global partners in the NTM-Network European Trials Group (NET) framework (www.ntm-net.org), a branch of the Tuberculosis Network European Trials Group (TB-NET), provided identification results of the total number of patients in 2008 in whom NTM were isolated from pulmonary samples. From these data, we visualised the relative distribution of the different NTM found per continent and per country. We received species identification data for 20 182 patients, from 62 laboratories in 30 countries across six continents. 91 different NTM species were isolated. Mycobacterium avium complex (MAC) bacteria predominated in most countries, followed by M. gordonae and M. xenopi. Important differences in geographical distribution of MAC species as well as M. xenopi, M. kansasii and rapid-growing mycobacteria were observed. This snapshot demonstrates that the species distribution among NTM isolates from pulmonary specimens in the year 2008 differed by continent and differed by country within these continents. These differences in species distribution may partly determine the frequency and manifestations of pulmonary NTM disease in each geographical location.

Entities:  

Mesh:

Year:  2013        PMID: 23598956     DOI: 10.1183/09031936.00149212

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  234 in total

1.  Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.

Authors:  Aurélie Renvoisé; Florence Brossier; Eve Galati; Nicolas Veziris; Wladimir Sougakoff; Alexandra Aubry; Jérôme Robert; Emmanuelle Cambau; Vincent Jarlier; Christine Bernard
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

2.  Natural disasters and nontuberculous mycobacteria: a recipe for increased disease?

Authors:  Jennifer R Honda; Jon N Bernhard; Edward D Chan
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

Review 3.  Management of nontuberculous mycobacterial infection in the elderly.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Golnaz Ebrahimi; Stefano Aliberti; Joseph O Falkinham
Journal:  Eur J Intern Med       Date:  2014-03-29       Impact factor: 4.487

4.  Nontuberculous mycobacteria in respiratory specimens: clinical significance at a tertiary care hospital in the north of Portugal.

Authors:  Hans Dabó; Vanessa Santos; Anabela Marinho; Angélica Ramos; Teresa Carvalho; Manuela Ribeiro; Adelina Amorim
Journal:  J Bras Pneumol       Date:  2015 May-Jun       Impact factor: 2.624

5.  Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of Mycobacterium avium Infection.

Authors:  Jean-Philippe Lanoix; Cédric Joseph; François Peltier; Sandrine Castelain; Claire Andréjak
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

6.  Species Distribution and Macrolide Susceptibility of Mycobacterium fortuitum Complex Clinical Isolates.

Authors:  Su-Young Kim; Seong Mi Moon; Byung Woo Jhun; O Jung Kwon; Hee Jae Huh; Nam Yong Lee; Seung Heon Lee; Sung Jae Shin; Shannon H Kasperbauer; Gwen A Huitt; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

7.  Regional differences of nontuberculous mycobacteria species in Ulsan, Korea.

Authors:  Mu Yeol Lee; Taehoon Lee; Min Ho Kim; Sung Soo Byun; Myung Kwan Ko; Jung Min Hong; Kyung Hoon Kim; Seung Won Ra; Kwang Won Seo; Yangjin Jegal; Joseph Jeong; Jong Joon Ahn
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

8.  Implementation of MALDI-TOF MS technology for the identification of clinical isolates of Mycobacterium spp. in mycobacterial diagnosis.

Authors:  G Tudó; M R Monté; A Vergara; A López; J C Hurtado; M Ferrer-Navarro; J Vila; J Gonzalez-Martin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-26       Impact factor: 3.267

9.  Case Report: Disseminated Mycobacterium kansasii Disease in a Patient with Anti-Interferon-Gamma Antibody.

Authors:  Eriko Kashihara; Kohei Fujita; Naohiro Uchida; Yuki Yamamoto; Tadashi Mio; Hiroshi Koyama
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

10.  Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.

Authors:  Emily Henkle; Timothy Aksamit; Alan Barker; Charles L Daley; David Griffith; Philip Leitman; Amy Leitman; Elisha Malanga; Theodore K Marras; Kenneth N Olivier; D Rebecca Prevots; Delia Prieto; Alexandra L Quittner; William Skach; John W Walsh; Kevin L Winthrop
Journal:  Ann Am Thorac Soc       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.